Page results
-
The Com-Cov trial in which UCLH is a site looking at alternating vaccines has been expanded to include the Moderna and Novavax vaccines.
-
A patient with motor neurone disease was able to control a computer just by using his thoughts following the UK’s first Neuralink implant surgery at UCLH’s National Hospital for Neurology and Neurosurgery (NHNN) in October 2025.
-
Our Getting Ready for Transition (GReaT) to secondary school parent information session will run on Wednesday 28 January 2026.
-
UCLH is to lead an initiative to improve care for myeloma patients alongside Oxford University Hospitals NHS Foundation Trust (OUH) and University Hospital Southampton NHS Foundation Trust (UHS).
-
Mild Covid-19 infection is very unlikely to cause lasting damage to the structure or function of the heart, according to a study supported by the NIHR UCLH Biomedical Research Centre and UCLH Charity.
-
UCLH Director of Research Professor Bryan Williams and Consultant Neuropsychologist at UCLH Professor Lisa Cipolotti have been elected Fellows of the Academy of Medical Sciences in recognition of their exceptional contributions to biomedical and health science.
-
People infected with coronavirus have a distinct odour that can be detected by trained dogs with a high degree of accuracy, according to new research involving UCLH.
-
Psychological guidance to help you prepare, cope, and recover.
-
A team of clinicians and researchers at UCLH and UCL have been awarded a £2.8 million grant to combat health inequalities in patients having major surgery.
-
Researchers at the NIHR UCLH Clinical Research Facility are the first in the world to start a new first-in-human trial investigating a novel treatment, called NVG-111, in patients with Non-Hodgkin lymphoma (NHL) subtypes.
File results
-
Council of Governors meeting papers - 31 October
-
Consultant - to -consultant referral form
-
UCLH Provider to Provider Tariff 2019-20
-
What young people would like everyone to know about Type 1 Diabetes
-
Reverse mentoring
-
FOI/2020/0572 - Inflamatory bowel disease staff contact details
-
FOI2017294 Contactors and subcontractors working on the Phase 4 and proton therapy beam
-
FOI/2020/0589 - Senior staff contacts for CEO, Director of Innovation and Chief Pharmacist
-
FOI/2020/0630 - CEO, Operations Director and Health and Safety Director contact details
-
FOI2017333 Midwifery contacts for accessing return to practice placements